The relationship between atypical antipsychotics drugs, QT interval prolongation, and torsades de pointes: implications for clinical use

References

• Sims AC. Mortality statistics in psychiatry. Br J Psychiatry. 2001 Dec;179:477–478.
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang X, Qin X, et al. Antipsychotics and risk of natural death in patients with schizophrenia. Neuropsychiatr Dis Treat. 2019;15:1863–1871.
   PubMed Web of Science ®Google Scholar
• Chi Shin Wu Y-TS, Hui-Ju T. Antipsychotic drugs and the risk of ventricular arrhythmia and/or sudden cardiac death: a nation-wide case-crossover study. JAHA. 2015;4(2). pii:e001568,
   Google Scholar
• Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000 Sep;177:212–217.
   PubMed Web of Science ®Google Scholar
• Brown S. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry. 1997 Dec;171:502–508.
   PubMed Web of Science ®Google Scholar
• Jeste DV, Gladsjo JA, Lindamer LA, et al. Medical comorbidity in schizophrenia. Schizophr Bull. 1996;22(3):413–430.
   PubMed Web of Science ®Google Scholar
• Murray-Thomas T, Jones ME, Patel D, et al. Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database. Cardiovasc Psychiatry Neurol. 2013;2013:247486.
   PubMedGoogle Scholar
• Olfson M, Gerhard T, Huang C, et al. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015 Dec;72(12):1172–1181.
   PubMed Web of Science ®Google Scholar
• Fan Z, Wu Y, Shen J, et al. Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies. J Psychiatr Res. 2013 Nov;47(11):1549–1556.
   PubMed Web of Science ®Google Scholar
• Capasso RM, Lineberry TW, Bostwick JM, et al. Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950–2005. Schizophr Res. 2008 Jan;98(1–3):287–294.
   PubMed Web of Science ®Google Scholar
• Mackin P. Cardiac side effects of psychiatric drugs. Hum Psychopharmacol. 2008 Jan;23(Suppl 1):3–14.
   PubMed Web of Science ®Google Scholar
• Ames D, Carr-Lopez SM, Gutierrez MA, et al. Detecting and managing adverse effects of antipsychotic medications: current state of play. Psychiatr Clin North Am. 2016 Jun;39(2):275–311.
   PubMed Web of Science ®Google Scholar
• Curtis LH, Ostbye T, Sendersky V, et al. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am J Med. 2003 Feb 1;114(2):135–141.
   PubMed Web of Science ®Google Scholar
• Postema PG, Wilde AA. The measurement of the QT interval. Curr Cardiol Rev. 2014 Aug;10(3):287–294.
   PubMedGoogle Scholar
• Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003 Nov;89(11):1363–1372.
   PubMed Web of Science ®Google Scholar
• Hlaing T, DiMino T, Kowey PR, et al. ECG repolarization waves: their genesis and clinical implications. Ann Noninvasive Electrocardiol. 2005 Apr;10(2):211–223.
   PubMed Web of Science ®Google Scholar
• Belardinelli L, Antzelevitch C, Vos MA. Assessing predictors of drug-induced torsades de pointes. Trends Pharmacol Sci. 2003 Dec;24(12):619–625.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Reinier K, Singh T, et al. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon sudden unexpected death study. Circulation. 2009 Feb 10;119(5):663–670.
   PubMed Web of Science ®Google Scholar
• Drolet B, Vincent F, Rail J, et al. Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current. J Pharmacol Exp Ther. 1999 Mar;288(3):1261–1268.
   PubMed Web of Science ®Google Scholar
• Locati ET, Bagliani G, Padeletti L. Normal ventricular repolarization and QT interval: ionic background, modifiers, and measurements. Card Electrophysiol Clin. 2017 Sep;9(3):487–513.
   PubMedGoogle Scholar
• Yan GX, Lankipalli RS, Burke JF, et al. Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance. J Am Coll Cardiol. 2003 Aug 6;42(3):401–409.
   PubMed Web of Science ®Google Scholar
• Lankipalli RS, Zhu T, Guo D, et al. Mechanisms underlying arrhythmogenesis in long QT syndrome. J Electrocardiol. 2005 Oct;38(4 Suppl):69–73.
   PubMed Web of Science ®Google Scholar
• Viskin S. Long QT syndromes and torsades de pointes. Lancet. 1999 Nov 6;354(9190):1625–1633.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, LaPointe NM, Kramer JM, et al. What clinicians should know about the QT interval. JAMA. 2003 Apr 23–30;289(16):2120–2127.
   PubMed Web of Science ®Google Scholar
• Anderson ME, Al-Khatib SM, Roden DM, et al. Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management. Am Heart J. 2002 Nov;144(5):769–781.
   PubMed Web of Science ®Google Scholar
• Chan A, Isbister G, Kirkpatrick C, et al. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. Q J Med. 2007;100:609–615.
   Google Scholar
• Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsades de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010 Mar 2;121(8):1047–1060.
   PubMed Web of Science ®Google Scholar
• Algra A, Tijssen JG, Roelandt JR, et al. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation. 1991 Jun;83(6):1888–1894.
   PubMed Web of Science ®Google Scholar
• van Noord C, Sturkenboom MC, Straus SM, et al. Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death. Heart. 2011 Feb;97(3):215–220.
   PubMed Web of Science ®Google Scholar
• Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002 Feb;47(1):27–38.
   PubMed Web of Science ®Google Scholar
• Hollister LE, Kosek JC. Sudden death during treatment with phenothiazine derivatives. JAMA. 1965 Jun;21(192):1035–1038.
   Web of Science ®Google Scholar
• Giles TD, Modlin RK. Death associated with ventricular arrhythmia and thioridazine hydrochloride. JAMA. 1968 Jul 8;205(2):108–110.
   PubMed Web of Science ®Google Scholar
• Witton K. Phenothiazines and sudden death. JAMA. 1965 Nov 8;194(6):679.
   PubMed Web of Science ®Google Scholar
• Granger ME. Phenothiazines and sudden death. JAMA. 1965 Nov 8;194(6):678–679.
   PubMed Web of Science ®Google Scholar
• Mehtonen OP, Aranko K, Malkonen L, et al. A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatr Scand. 1991 Jul;84(1):58–64.
   PubMed Web of Science ®Google Scholar
• Heist EK, Ruskin JN. Drug-induced proarrhythmia and use of QTc-prolonging agents: clues for clinicians. Heart Rhythm. 2005 Nov;2(2 Suppl):S1–S8.
   PubMed Web of Science ®Google Scholar
• Ray WA, Meredith S, Thapa PB, et al. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry. 2001 Dec;58(12):1161–1167.
   PubMed Web of Science ®Google Scholar
• Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009 Jan 15;360(3):225–235.
   PubMed Web of Science ®Google Scholar
• Leucht A, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013 Sept 14;382:951–962.
   PubMed Web of Science ®Google Scholar
• Roden D. Drug-induced prolongation of the QT interval. N Engl J Med. 2004 March 4;350:1013–1022.
   PubMed Web of Science ®Google Scholar
• Carrà G, Crocamo C, Bartoli F, et al. First-generation antipsychotics and QTc: any role for mediating variables? Hum Psychopharmacol. 2016;31(4):313–318. Epub 2016/ 06/01. PubMed PMID: 27245736.
   PubMed Web of Science ®Google Scholar
• Barbui C, Bighelli I, Carrà G, et al. Antipsychotic dose mediates the association between polypharmacy and corrected QT interval. PLoS One. 2016;11(2):e0148212. Epub 2016/02/03. PubMed PMID: 26840602; PubMed Central PMCID: PMCPMC4739745.
   PubMed Web of Science ®Google Scholar
• Ifteni P, Correll C, Burtea V, et al. Sudden cardiac death: autopsy findings in 7200 cases between 2001 and 2015. Schizophr Res. 2014;155(1–3):72–76. Epub 4 April 2014.
   PubMed Web of Science ®Google Scholar
• Acciavatti T, Martinotti G, Di Giannantonio M. Sudden cardiac death related to antipsychotics: beyond the long QT syndrome hypothesis. J Clin Psychiatry. 2016;775:e600. PubMed PMID: 27249087.
   PubMed Web of Science ®Google Scholar
• Honkola J, Hookana E, Malinen S, et al. Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Eur Heart J. 2012;33(6):745–751. Epub 2011/09/14. PubMed PMID: 21920969.
   PubMed Web of Science ®Google Scholar
• Titier K, Girodet PO, Verdoux H, et al. Atypical antipsychotics: from potassium channels to torsades de pointes and sudden death. Drug Saf. 2005;28(1):35–51.
   PubMed Web of Science ®Google Scholar
• Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsades de pointes and sudden death. Drugs. 2002;62(11):1649–1671.
   PubMed Web of Science ®Google Scholar
• Bednar MM, Harrigan EP, Anziano RJ, et al. The QT interval. Prog Cardiovasc Dis. 2001 Mar-Apr;43(5 Suppl 1):1–45.
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Avorn J. Antipsychotic agents and sudden cardiac death–how should we manage the risk? N Engl J Med. 2009 Jan 15;360(3):294–296.
   PubMed Web of Science ®Google Scholar
• Vincent GM, Timothy KW, Leppert M, et al. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992 Sep 17;327(12):846–852.
   PubMed Web of Science ®Google Scholar
• Zareba W, Moss AJ, Schwartz PJ, et al. Influence of the genotype on the clinical course of the long-QT syndrome. international long-QT syndrome registry research group. N Engl J Med. 1998 Oct 1;339(14):960–965.
   PubMed Web of Science ®Google Scholar
• Fanoe S, Kristensen D, Fink-Jensen A, et al. Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management. Eur Heart J. 2014 May 21;35(20):1306–1315.
   PubMed Web of Science ®Google Scholar